TransMedics Group, Inc. (TMDX) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Revenue Year Over Year Growth | 21.20 percent | FY2026-Q1 |
| Gross Margin | 58.10 percent | FY2026-Q1 |
| Service Revenue | 65.96M | FY2026-Q1 |
| Operating Margin | 7.60 percent | FY2026-Q1 |
| Service Revenue Year Over Year Growth | 19.30 percent | FY2026-Q1 |
| Net Product Revenue | 107.97M | FY2026-Q1 |
| Owned Aircraft Count | 22.00 | FY2026-Q1 |
| Adjusted Net Income | 10.91M | FY2026-Q1 |
| Adjusted Diluted Net Income per Share | 0.30 USD_per_share | FY2026-Q1 |
| Non-Standard Donation Coverage | 82.00 percent | FY2026-Q1 |
| Net Income as a Percentage of Revenue | 66.00 percent | FY2025-Q4 |
Back to TMDX overview · TMDX earnings · TMDX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.